Latest Insider Transactions at Silk Road Medical Inc (SILK)
This section provides a real-time view of insider transactions for Silk Road Medical Inc (SILK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Silk Road Medical Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Silk Road Medical Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 14
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,600
+3.92%
|
$38,400
$4.73 P/Share
|
|
Oct 12
2020
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
20,044
-15.23%
|
$1,322,904
$66.16 P/Share
|
|
Oct 12
2020
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,044
+13.21%
|
$20,044
$1.46 P/Share
|
|
Oct 01
2020
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,635
-25.1%
|
$431,275
$65.6 P/Share
|
|
Oct 01
2020
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,635
+20.06%
|
$6,635
$1.46 P/Share
|
|
May 05
2020
|
Warburg Pincus & Co. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,885,078
-82.71%
|
$190,518,042
$39.0 P/Share
|
|
Nov 26
2019
|
Warburg Pincus & Co. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,500,000
-20.25%
|
$52,500,000
$35.0 P/Share
|
|
Apr 08
2019
|
Norwest Venture Partners Xiii, LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,764
+0.15%
|
$30,112
$8.27 P/Share
|
|
Apr 08
2019
|
Norwest Venture Partners Xiii, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,458,210
+50.0%
|
-
|